RNA-binding proteins control gene expression and cell fate in the immune system

M Turner, MD Díaz-Muñoz - Nature immunology, 2018 - nature.com
RNA-binding proteins (RBPs) are essential for the development and function of the immune
system. They interact dynamically with RNA to control its biogenesis and turnover by …

[HTML][HTML] Dual-specificity MAP kinase phosphatases in health and disease

OM Seternes, AM Kidger, SM Keyse - Biochimica et Biophysica Acta (BBA) …, 2019 - Elsevier
It is well established that a family of dual-specificity MAP kinase phosphatases (MKPs) play
key roles in the regulated dephosphorylation and inactivation of MAP kinase isoforms in …

[HTML][HTML] DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK …

Q Jin, R Li, N Hu, T Xin, P Zhu, S Hu, S Ma, H Zhu… - Redox biology, 2018 - Elsevier
Mitochondrial fission and selective mitochondrial autophagy (mitophagy) form an essential
axis of mitochondrial quality control that plays a critical role in the development of cardiac …

Dynamic ligand discrimination in the notch signaling pathway

N Nandagopal, LA Santat, L LeBon, D Sprinzak… - Cell, 2018 - cell.com
The Notch signaling pathway comprises multiple ligands that are used in distinct biological
contexts. In principle, different ligands could activate distinct target programs in signal …

[HTML][HTML] Subtype-specific regulatory network rewiring in acute myeloid leukemia

SA Assi, MR Imperato, DJL Coleman, A Pickin… - Nature …, 2019 - nature.com
Acute myeloid leukemia (AML) is a heterogeneous disease caused by a variety of
alterations in transcription factors, epigenetic regulators and signaling molecules. To …

Druggable cancer phosphatases

JP Vainonen, M Momeny, J Westermarck - Science translational …, 2021 - science.org
The phosphorylation status of oncoproteins is regulated by both kinases and phosphatases.
Kinase inhibitors are rarely sufficient for successful cancer treatment, and phosphatases …

Targeting phosphatases and kinases: How to checkmate cancer

A Turdo, C D'Accardo, A Glaviano, G Porcelli… - Frontiers in cell and …, 2021 - frontiersin.org
Metastatic disease represents the major cause of death in oncologic patients worldwide.
Accumulating evidence have highlighted the relevance of a small population of cancer cells …

Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML

C Liu, W Zou, D Nie, S Li, C Duan, M Zhou, P Lai… - Cell metabolism, 2022 - cell.com
Our group has reported previously on the role of various members of the protein arginine
methyltransferase (PRMT) family, which are involved in epigenetic regulation, in the …

Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML disease

MT Scott, W Liu, R Mitchell, CJ Clarke… - Nature …, 2024 - nature.com
Whilst it is recognised that targeting self-renewal is an effective way to functionally impair the
quiescent leukaemic stem cells (LSC) that persist as residual disease in chronic myeloid …

Treatment-free remission in CML: who, how, and why?

FX Mahon - Hematology 2014, the American Society of …, 2017 - ashpublications.org
Chronic myeloid leukemia (CML) is the best example of successful targeted therapy. Today,
the overall survival of patients with CML treated by using tyrosine kinase inhibitors (TKIs) is …